Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AVALGLUCOSIDASE ALFA-NGPT vs AVANAFIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AVALGLUCOSIDASE ALFA-NGPT vs AVANAFIL: Safety Overview

Metric AVALGLUCOSIDASE ALFA-NGPT AVANAFIL
Total FAERS Reports 741 537
Deaths Reported 3 4
Death Rate 0.4% 0.7%
Hospitalizations 74 26
Average Patient Age 38.0 yrs 64.2 yrs
% Female Patients 54.5% 0.2%
FDA Approval Date N/A Apr 27, 2012
Manufacturer N/A Camber Pharmaceuticals, Inc.
Route N/A ORAL
Marketing Status Prescription Prescription